Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature Medicine 8, 1004 - 1010 (2002)
Published online: 29 July 2002 | doi:10.1038/nm744
Bone marrow–derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis
Atsushi Otani1, Karen Kinder1, Karla Ewalt2, Francella J. Otero2, Paul Schimmel2 & Martin Friedlander1
Abstract
Adult bone marrow (BM) contains cells capable of differentiating along hematopoietic (Lin+) or non-hematopoietic (Lin-) lineages. Lin- hematopoietic stem cells (HSCs) have recently been shown to contain a population of endothelial precursor cells (EPCs) capable of forming blood vessels. Here we show that intravitreally injected Lin- BM cells selectively target retinal astrocytes, cells that serve as a template for both developmental and injury-associated retinal angiogenesis. When Lin- BM cells were injected into neonatal mouse eyes, they extensively and stably incorporated into forming retinal vasculature. When EPC-enriched HSCs were injected into the eyes of neonatal rd/rd mice, whose vasculature ordinarily degenerates with age, they rescued and maintained a normal vasculature. In contrast, normal retinal angiogenesis was inhibited when EPCs expressing a potent angiostatic protein were injected. We have demonstrated that Lin- BM cells and astrocytes specifically interact with one another during normal angiogenesis and pathological vascular degeneration in the retina. Selective targeting with Lin- HSC may be a useful therapeutic approach for the treatment of many ocular diseases.
To read this story in full you will need to login or make a payment (see right).
|
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated NEWS AND VIEWS RESEARCH |
